Free tool
FAERS Monitor: Edluar
Last checked: Nov 19, 2026FDA FAERS (openFDA) last updated: Oct 28, 2026Methods & limitations
Reports naming NDA 021997 or its brand name (Edluar, Zolpidem Tartrate). Reports on generic versions are filed under their own applications.
Reports
24,224
Serious
18,178
75% of reports
Hospitalization
9,226
Death reported
3,298
Any cause; not necessarily from the drug
Most reported reactions
MedDRA preferred terms.
- drug ineffective1,466
- nausea1,248
- fatigue1,173
- insomnia997
- diarrhoea941
- fall935
- headache920
- completed suicide894
- pain812
- vomiting808
- dizziness801
- somnolence778
- drug abuse772
- dyspnoea771
- toxicity to various agents765
Reports by year received
View as table
| Year | Reports |
|---|---|
| 2004 | 528 |
| 2005 | 572 |
| 2006 | 578 |
| 2007 | 726 |
| 2008 | 618 |
| 2009 | 604 |
| 2010 | 600 |
| 2011 | 660 |
| 2012 | 875 |
| 2013 | 603 |
| 2014 | 609 |
| 2015 | 1,083 |
| 2016 | 1,591 |
| 2017 | 1,309 |
| 2018 | 1,686 |
| 2019 | 1,476 |
| 2020 | 1,330 |
| 2021 | 1,245 |
| 2022 | 1,571 |
| 2023 | 1,543 |
| 2024 | 1,688 |
| 2025 | 1,541 |
| 2026 | 1,188 |
Disproportionality screen
Proportional reporting ratio (PRR): how much more often each reaction appears in this drug's reports than in the other 21,029,935 FAERS reports. Flagged when PRR is at least 2, chi-squared at least 4 and there are 3 or more reports (Evans criteria). A screening statistic only.
| Reaction | Reports | PRR | 95% CI lower | Chi-squared |
|---|---|---|---|---|
| completed suicideSignal | 894 | 9.4 | 8.8 | 6,661 |
| drug abuseSignal | 772 | 8.1 | 7.6 | 4,786 |
| toxicity to various agentsSignal | 765 | 4.0 | 3.7 | 1,690 |
| somnolenceSignal | 778 | 3.4 | 3.1 | 1,298 |
| insomniaSignal | 997 | 3.3 | 3.1 | 1,573 |
| fallSignal | 935 | 2.4 | 2.3 | 806 |
| vomiting | 808 | 1.5 | 1.4 | 134 |
| dizziness | 801 | 1.4 | 1.3 | 91 |
| nausea | 1,248 | 1.4 | 1.3 | 129 |
| fatigue | 1,173 | 1.3 | 1.2 | 88 |
| headache | 920 | 1.3 | 1.2 | 56 |
| diarrhoea | 941 | 1.3 | 1.2 | 54 |
| dyspnoea | 771 | 1.2 | 1.1 | 22 |
| pain | 812 | 1.1 | 1.1 | 16 |
| drug ineffective | 1,466 | 1.0 | 0.9 | 2 |
A high PRR for a reaction that is also the condition being treated (for example "disease progression" for a cancer drug) is expected and is not a safety signal.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.